MA H898

Bill

Relative to consumer deductibles

Introduced
01/22/2019

In Committee
01/22/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to the cost of prescription drugs. Financial Services.

AI Summary

This bill amends Chapter 176O of the General Laws to require health insurance carriers to include any third-party payments, financial assistance, discounts, product vouchers, or other reductions in out-of-pocket expenses made on behalf of an insured individual when calculating the individual's overall contribution to any out-of-pocket maximum, deductible, copayment, coinsurance, or other cost-sharing requirement for prescription drugs. The bill also empowers the Commission to promulgate any necessary rules and regulations to implement this new requirement.

Committee Categories

Business and Industry

Sponsors (1)

Jim Arciero (D),

Last Action

Accompanied a study order, see H5160 (on 12/01/2020)

Official Document

https://malegislature.gov/Bills/191/H898

(14 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/H898
Bill	https://malegislature.gov/Bills/191/H898.pdf

Bill	Bill Name	Last Action	Type
H1162	To promote transparency in prescription drug prices	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1860	Relative to the dispensing of prescription drugs	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1913	Authorizing a 90-day supply of medically necessary testosterone therapy medication	Accompanied a study order, see H4449	Similar To
H1972	To permit the wholesale importation of prescription drugs into the Commonwealth	Accompanied a study order, see H4449	Similar To
H5160	Study Order - payments and insurance	Discharged to the committee on House Rules	Replaced by
H926	Relative to consumer deductibles	Accompanied a study order, see H5160	Similar To
S1149	Strengthening prescription drug safety and drug stewardship	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S1277	Relative to the prescription monitoring program	Accompanied a study order, see S2683	Similar To
S2397	Relative to pharmaceutical access, costs and transparency	Reprinted as amended, see S2409	Similar To
S2409	Relative to pharmaceutical access, costs and transparency	Read; and referred to the committee on House Ways and Means	Similar To
S552	To promote transparency in prescription drug prices	Accompanied a study order, see S2543	Similar To
S570	Relative to out-of-pocket expenses for prescription drug coverage	Accompanied a study order, see S2543	Similar To
S582	Ensuring access to medications	Accompanied a study order, see S2543	Similar To
S721	Relative to mandatory prescription drug coverage	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To

Bill

Bill Name

Last Action

Type

H1162

To promote transparency in prescription drug prices

Reporting date extended to Thursday December 31, 2020, pending concurrence

Similar To

H1860

Relative to the dispensing of prescription drugs

Reporting date extended to Thursday December 31, 2020, pending concurrence

Similar To

H1913

Authorizing a 90-day supply of medically necessary testosterone therapy medication

Accompanied a study order, see H4449

Similar To

H1972

To permit the wholesale importation of prescription drugs into the Commonwealth

Accompanied a study order, see H4449

Similar To

H5160

Study Order - payments and insurance

Discharged to the committee on House Rules

Replaced by

H926

Relative to consumer deductibles

Accompanied a study order, see H5160

Similar To

S1149

Strengthening prescription drug safety and drug stewardship

Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session

Similar To

S1277

Relative to the prescription monitoring program

Accompanied a study order, see S2683

Similar To

S2397

Relative to pharmaceutical access, costs and transparency

Reprinted as amended, see S2409

Similar To

S2409

Relative to pharmaceutical access, costs and transparency

Read; and referred to the committee on House Ways and Means

Similar To

S552

To promote transparency in prescription drug prices

Accompanied a study order, see S2543

Similar To

S570

Relative to out-of-pocket expenses for prescription drug coverage

Accompanied a study order, see S2543

Similar To

S582

Ensuring access to medications

Accompanied a study order, see S2543

Similar To

S721

Relative to mandatory prescription drug coverage

Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session

Similar To

Bill > H898

MA H898

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (1)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary